| Date Checked | 2026-02-19 22:13:34 |
|---|---|
| Graham Number | (PB)30.02 vs (PE)43.63 |
| Over / Under Value Percentage | 182.26% vs 136.94% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | EW |
| AssetType | Common Stock |
| Name | Edwards Lifesciences Corp |
| Description | Edwards Lifesciences Corp is a premier American medical technology firm headquartered in Irvine, California, focusing on advanced heart valve therapies and hemodynamic monitoring solutions. The company is widely recognized for its innovative transcatheter heart valve technologies, which are designed to improve the clinical outcomes and quality of life for patients with heart diseases. With a strong product portfolio and a promising pipeline of groundbreaking technologies, Edwards Lifesciences is well-positioned to lead advancements in cardiac care, while delivering sustainable growth and long-term value for stakeholders in the evolving healthcare landscape. |
| CIK | 1099800 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL DEVICES |
| Address | ONE EDWARDS WAY, IRVINE, CA, UNITED STATES, 92614 |
| OfficialSite | https://www.edwards.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 49656922000 |
| EBITDA | 1788400000 |
| PERatio | 37.1 |
| PEGRatio | 4.779 |
| BookValue | 17.57 |
| DividendPerShare | None |
| EPS | 2.28 |
| RevenuePerShareTTM | 10.02 |
| ProfitMargin | 0.233 |
| OperatingMarginTTM | 0.274 |
| ReturnOnAssetsTTM | 0.0772 |
| ReturnOnEquityTTM | 0.135 |
| RevenueTTM | 5883800000 |
| GrossProfitTTM | 4600400000 |
| DilutedEPSTTM | 2.28 |
| QuarterlyEarningsGrowthYOY | -0.903 |
| QuarterlyRevenueGrowthYOY | 0.147 |
| AnalystTargetPrice | 96.05 |
| AnalystRatingStrongBuy | 5 |
| AnalystRatingBuy | 15 |
| AnalystRatingHold | 13 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 37.1 |
| ForwardPE | 29.85 |
| PriceToSalesRatioTTM | 8.44 |
| PriceToBookRatio | 4.824 |
| EVToRevenue | 7.83 |
| EVToEBITDA | 24.73 |
| Beta | 0.955 |
| 52WeekHigh | 87.89 |
| 52WeekLow | 65.94 |
| 50DayMovingAverage | 84.74 |
| 200DayMovingAverage | 78.23 |
| SharesOutstanding | 580300000 |
| SharesFloat | 574427000 |
| PercentInsiders | 0.919 |
| PercentInstitutions | 90.125 |
| ExDividendDate | None |
| dateChecked | 2026-02-19 22:13:34 |
| fresh | 1 |